Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul

Apr 20 2009

• By Katie Stevenson

Related Content

FDA Public Workshop To Gain Insight Into Profit-Motivated Adulteration

Mar 09 2009

The Council Navigates “Demanding” Year, Prepares For Liberal Legislation

Mar 02 2009

Tobacco Oversight Looks More Likely, But Is It Bad For FDA’s Health?

Mar 09 2009

Sharfstein Is Acting FDA Commissioner As Hamburg Awaits Confirmation

Mar 30 2009

Lafe’s Natural Bodycare Touts ‘Baby-Safe Plastic’ In New Line Of Baby Items

Aug 25 2008

Jan Marini Focused On Damage Control Following FDA Seizure Of Eyelash Item

Nov 26 2007

More Salmonella Problems Point To Holes In Food GMPs

Apr 06 2009

FDA Scientists Say Plan B Decision-Makers At CDER “Should Be Removed”

Apr 06 2009

Waxman Takes Legislative Driver’s Seat With Energy &amp; Commerce Move

Nov 24 2008

FDA Faces “Conundrum” In Determining Efficacy Of Children’s Cold Products

Oct 06 2008

More from Archive

More from HBW Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window